|
DE19701949A1
(de)
*
|
1997-01-13 |
1998-07-16 |
Jenapharm Gmbh |
Transdermales therapeutisches System
|
|
US6319913B1
(en)
*
|
1997-11-10 |
2001-11-20 |
Cellegy Pharmaceuticals, Inc. |
Penetration enhancing and irritation reducing systems
|
|
JP3987655B2
(ja)
*
|
1998-03-03 |
2007-10-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
抗痴呆薬を含有した経皮適用製剤又は坐剤
|
|
FR2776191B1
(fr)
*
|
1998-03-23 |
2002-05-31 |
Theramex |
Composition hormonale topique a effet systemique
|
|
GB9828480D0
(en)
*
|
1998-12-24 |
1999-02-17 |
Dermatech Limited |
Transdermal drug delivery system
|
|
CA2381425A1
(en)
|
1999-08-24 |
2001-03-01 |
Cellgate, Inc. |
Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
|
|
DE10019171A1
(de)
*
|
2000-04-07 |
2001-10-18 |
Schering Ag |
Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
|
|
JP2003531157A
(ja)
*
|
2000-04-26 |
2003-10-21 |
ワトソン ファーマシューティカルズ， インコーポレイテッド |
オキシブチニン治療に関連した有害な経験の最小化
|
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
US7029694B2
(en)
*
|
2000-04-26 |
2006-04-18 |
Watson Laboratories, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
DE10025970C2
(de)
*
|
2000-05-25 |
2002-04-25 |
Lohmann Therapie Syst Lts |
Estrogenhaltiges Pflaster mit einem Wirkstoffreservoir auf der Basis von Ethylcellulose und einem Ethylen-Vinylacetat-Vinylpyrrolidon-Copolymer und seine Verwendung
|
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
|
ATE355854T1
(de)
*
|
2000-08-03 |
2007-03-15 |
Antares Pharma Ipl Ag |
Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
US7198801B2
(en)
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
US6503894B1
(en)
*
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
|
US20030027804A1
(en)
*
|
2001-06-27 |
2003-02-06 |
Van Der Hoop Roland Gerritsen |
Therapeutic combinations for the treatment of hormone deficiencies
|
|
US20040062794A1
(en)
*
|
2002-09-30 |
2004-04-01 |
Lee Shulman |
17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
|
|
FR2848112B1
(fr)
*
|
2002-12-10 |
2007-02-16 |
Besins Int Belgique |
Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations
|
|
US7572780B2
(en)
*
|
2003-01-21 |
2009-08-11 |
Dimera, Incorporated |
Method and kit for reducing the symptoms of peripheral vascular disease
|
|
FR2851470B1
(fr)
|
2003-02-20 |
2007-11-16 |
Besins Int Belgique |
Composition pharmaceutique pour administration transdermique ou transmuqueuse
|
|
US20040253326A1
(en)
*
|
2003-02-25 |
2004-12-16 |
Mesko Charles A. |
Composition for increasing levels of hormones and a method for preparation of said composition
|
|
CN1997357A
(zh)
*
|
2003-03-11 |
2007-07-11 |
安塔雷斯制药Ipl股份公司 |
透皮或透粘膜应用活性剂的用途和制剂
|
|
US7858607B2
(en)
*
|
2003-03-14 |
2010-12-28 |
Mamchur Stephen A |
System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
|
|
US7879357B2
(en)
|
2003-04-28 |
2011-02-01 |
Bayer Schering Pharma Ag |
Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
|
|
JO2492B1
(en)
|
2003-04-28 |
2009-10-05 |
شيرينج ايه جي |
A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
|
|
US7387788B1
(en)
|
2003-10-10 |
2008-06-17 |
Antares Pharma Ipl Ag |
Pharmaceutical compositions of nicotine and methods of use thereof
|
|
DK1670433T3
(da)
|
2003-10-10 |
2012-03-12 |
Ferring Bv |
Transdermal farmaceutisk formulering til mindskelse af hudrester
|
|
US7780973B2
(en)
*
|
2003-12-15 |
2010-08-24 |
Ethicon Endo-Surgery, Inc. |
Method and device for minimally invasive implantation of biomaterial
|
|
US7425340B2
(en)
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
|
JP2007045808A
(ja)
*
|
2005-01-07 |
2007-02-22 |
Rohto Pharmaceut Co Ltd |
皮膚外用剤
|
|
JP4969050B2
(ja)
*
|
2005-01-07 |
2012-07-04 |
ロート製薬株式会社 |
皮膚外用剤
|
|
US20070088012A1
(en)
*
|
2005-04-08 |
2007-04-19 |
Woun Seo |
Method of treating or preventing type-2 diabetes
|
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
|
KR100699582B1
(ko)
|
2005-07-11 |
2007-03-23 |
삼성전기주식회사 |
출력 버퍼회로
|
|
ES3012497T3
(en)
|
2005-10-12 |
2025-04-09 |
Besins Healthcare Lu Sarl |
Improved testosterone gel and method of use
|
|
US20070254036A1
(en)
*
|
2006-04-13 |
2007-11-01 |
Besins Healthcare Sa |
Treatment of menopause associated symptoms
|
|
CA2646667C
(en)
|
2006-04-21 |
2014-03-11 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
|
US8507467B2
(en)
|
2007-09-20 |
2013-08-13 |
Shiseido Company, Ltd. |
Transdermally absorbable preparation
|
|
CA2730787A1
(en)
*
|
2008-07-16 |
2010-01-21 |
David M. Cohen |
Topical drug delivery system
|
|
US10080760B2
(en)
|
2009-10-27 |
2018-09-25 |
Besins Healthcare Luxembourg Sarl |
Transdermal pharmaceutical compositions comprising active agents
|
|
FR2954980B1
(fr)
|
2010-01-04 |
2012-02-10 |
Guillemot Corp |
Joystick a ressorts de compensation, procede de fabrication et manette correspondants.
|
|
US9757388B2
(en)
|
2011-05-13 |
2017-09-12 |
Acerus Pharmaceuticals Srl |
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
|
|
US20130045958A1
(en)
|
2011-05-13 |
2013-02-21 |
Trimel Pharmaceuticals Corporation |
Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
|
AR086400A1
(es)
|
2011-05-13 |
2013-12-11 |
Trimel Pharmaceuticals Corp |
Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
|
|
JP5820207B2
(ja)
|
2011-09-13 |
2015-11-24 |
日東電工株式会社 |
経皮吸収促進用組成物および貼付製剤
|
|
JP5820206B2
(ja)
|
2011-09-13 |
2015-11-24 |
日東電工株式会社 |
経皮吸収促進用組成物および貼付製剤
|
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
BR112014012444B1
(pt)
|
2011-11-23 |
2021-12-14 |
Therapeuticsmd, Inc |
Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
|
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11744838B2
(en)
|
2013-03-15 |
2023-09-05 |
Acerus Biopharma Inc. |
Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
|
|
RU2016143081A
(ru)
|
2014-05-22 |
2018-06-26 |
Терапьютиксмд, Инк. |
Натуральные комбинированные гормонозаместительные составы и терапии
|
|
RU2016141135A
(ru)
|
2014-07-29 |
2018-08-28 |
Терапьютиксмд, Инк. |
Трансдермальный крем
|
|
US10264664B1
(en)
|
2015-06-04 |
2019-04-16 |
Vlt, Inc. |
Method of electrically interconnecting circuit assemblies
|
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
|
US10493049B2
(en)
|
2016-02-10 |
2019-12-03 |
Niracle LLC |
Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations
|
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
|
US9931349B2
(en)
|
2016-04-01 |
2018-04-03 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
|
US10556717B2
(en)
|
2017-03-10 |
2020-02-11 |
E-Pac Packaging Services Co. Ltd. |
Packaging assembly comprising a tightening portion, a box portion, a flexible strip and a pair of securing members
|
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
|
EP4308088B1
(en)
|
2021-11-08 |
2025-03-12 |
Weiyong Li |
Transdermal drug delivery system for delivering a drug to a patient
|